AAAAAA

   
Results: 1-16 |
Results: 16
Physicians' perceptions of the benefits and risks of warfarin for patientswith nonvalvular atrial fibrillation
Authors: Bungard, TJ Ghali, WA McAlister, FA Buchan, AM Cave, AJ Hamilton, PG Mitchell, LB Shuaib, A Teo, KK Tsuyuki, RT
Citation: Tj. Bungard et al., Physicians' perceptions of the benefits and risks of warfarin for patientswith nonvalvular atrial fibrillation, CAN MED A J, 165(3), 2001, pp. 301-302
Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): Drug testing and as-treated analysis
Authors: Wyse, DG Talajic, M Hafley, GE Buxton, AE Mitchell, LB Kus, TK Packer, DL Kou, WH Lemery, R Santucci, P Grimes, D Hickey, K Stevens, C Singh, SN
Citation: Dg. Wyse et al., Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): Drug testing and as-treated analysis, J AM COL C, 38(2), 2001, pp. 344-351
Characterization of viable autofluorescent macrophages among cultured peripheral blood mononuclear cells
Authors: Njoroge, JM Mitchell, LB Centola, M Kastner, D Raffeld, M Miller, JL
Citation: Jm. Njoroge et al., Characterization of viable autofluorescent macrophages among cultured peripheral blood mononuclear cells, CYTOMETRY, 44(1), 2001, pp. 38-44
Resumption of driving after life-threatening ventricular tachyarrhythmia.
Authors: Akiyama, T Powell, JL Mitchell, LB Ehlert, FA Baessler, C
Citation: T. Akiyama et al., Resumption of driving after life-threatening ventricular tachyarrhythmia., N ENG J MED, 345(6), 2001, pp. 391-397
Comparison of dilated cardiomyopathy and coronary artery disease in patients with life-threatening ventricular arrhythmias: Differences in presentation and outcome in the AVID registry
Authors: Ehlert, FA Cannom, DS Renfroe, EG Greene, HL Ledingham, R Mitchell, LB Anderson, JL Halperin, BD Herre, JM Luceri, RM Marinchak, RA Steinberg, JS
Citation: Fa. Ehlert et al., Comparison of dilated cardiomyopathy and coronary artery disease in patients with life-threatening ventricular arrhythmias: Differences in presentation and outcome in the AVID registry, AM HEART J, 142(5), 2001, pp. 816-822
Validation of three myocardial jeopardy scores in a population-based cardiac catheterization cohort
Authors: Graham, MM Faris, PD Ghali, WA Galbraith, PD Norris, CM Badry, JT Mitchell, LB Curtis, MJ Knudtson, ML
Citation: Mm. Graham et al., Validation of three myocardial jeopardy scores in a population-based cardiac catheterization cohort, AM HEART J, 142(2), 2001, pp. 254-261
Baseline factors predicting early resumption of driving after life-threatening arrhythmias in the Antiarrhythmies Versus Implantable Defibrillators (AVID) Trial
Authors: Hickey, K Curtis, AB Lancaster, S Larsen, G Warwick, D McAnulty, J Mitchell, LB
Citation: K. Hickey et al., Baseline factors predicting early resumption of driving after life-threatening arrhythmias in the Antiarrhythmies Versus Implantable Defibrillators (AVID) Trial, AM HEART J, 142(1), 2001, pp. 99-104
Long-term survival in 11,661 patients with multivessel coronary artery disease in the era of stenting: A report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators
Authors: Dzavik, V Ghali, WA Norris, C Mitchell, LB Koshal, A Saunders, LD Galbraith, PD Hui, W Faris, P Knudtson, ML
Citation: V. Dzavik et al., Long-term survival in 11,661 patients with multivessel coronary artery disease in the era of stenting: A report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators, AM HEART J, 142(1), 2001, pp. 119-126
Conduction time oscillations precede the spontaneous termination of human atrioventricular reciprocating tachycardia
Authors: Exner, DV Mitchell, LB Wyse, DG Sheldon, RS Gillis, AM Cassidy, P Duff, HJ
Citation: Dv. Exner et al., Conduction time oscillations precede the spontaneous termination of human atrioventricular reciprocating tachycardia, J INTERV C, 4(1), 2000, pp. 231-239
Treatment approaches for patients with sustained VT/VF
Authors: Mitchell, LB Roy, D
Citation: Lb. Mitchell et D. Roy, Treatment approaches for patients with sustained VT/VF, CAN J CARD, 16, 2000, pp. 23C-25C
The role of prophylactic implantable cardioverter defibrillators to prevent sudden cardiac death
Authors: Talajic, M Mitchell, LB Hadjis, T
Citation: M. Talajic et al., The role of prophylactic implantable cardioverter defibrillators to prevent sudden cardiac death, CAN J CARD, 16, 2000, pp. 26C-28C
Simple modified ultrafiltration
Authors: Myers, GJ Leadon, RB Mitchell, LB Ross, DB
Citation: Gj. Myers et al., Simple modified ultrafiltration, PERFUSION-U, 15(5), 2000, pp. 447-452
Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Authors: Raj, SR Mitchell, LB Sheldon, RS
Citation: Sr. Raj et al., Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy., N ENG J MED, 343(1), 2000, pp. 68-68
Canadian implantable defibrillator study (CIDS) - A randomized trial of the implantable cardioverter defibrillator against amiodarone
Authors: Connolly, SJ Gent, M Roberts, RS Dorian, P Roy, D Sheldon, RS Mitchell, LB Green, MS Klein, GJ O'Brien, B
Citation: Sj. Connolly et al., Canadian implantable defibrillator study (CIDS) - A randomized trial of the implantable cardioverter defibrillator against amiodarone, CIRCULATION, 101(11), 2000, pp. 1297-1302
Prognostic significance of diabetes as a predictor of survival after cardiac catheterization
Authors: Ghali, WA Quan, H Norris, CM Dzavik, V Naylor, CD Mitchell, LB Brant, R Knudtson, ML
Citation: Wa. Ghali et al., Prognostic significance of diabetes as a predictor of survival after cardiac catheterization, AM J MED, 109(7), 2000, pp. 543-548
Atrial fibrillation: Electrophysiology, epidemiology, and assessment
Authors: Mitchell, LB Dorian, P
Citation: Lb. Mitchell et P. Dorian, Atrial fibrillation: Electrophysiology, epidemiology, and assessment, CAN J CARD, 15(4), 1999, pp. A1-A4
Risultati: 1-16 |